Bremelanotide (PT-141) Injectable

Method of Administration: Subcutaneous injection into fatty tissue.

Course Protocol: Administer the peptide 1 hour prior to sexual activity.

Injection Dose:

<90kg: 0.2ml (20 units on the insulin syringe) per injection.

>90kg: 0.25ml (25 units on the insulin syringe) per injection.

Storage Environment: 

Vials of PT141 Bremelanotide Should be kept in the refrigeratior (between 2-8°C)

Peptide vials should be stored in sealed plastic containers and kept away from other groceries in the refrigerator to prevent any risk of cross-contamination.

Pre-Loading Syringes:
Quality is not compromised by pre-loading syringes and storing them in the refrigerator for later use. You may also pre-load a syringe to use during the day but it is important to use it within a few hours of removing it from the fridge

Most people tolerate PT 141 well and do not get any side effects. However, below are a list of possible side effects noted in the Clinical Trials. These include:

• Facial flushing
• Reduced appetite
• Nausea

Peptides do not cause rapid changes in body composition nor should they be used in place of a healthy and balanced lifestyle. Peptides for weight loss purposes need to be accompanied by a calorie deficient diet and physical activity to be successful. Similarly, peptides for lean muscle addition need to be used in conjunction with a (temporary) calorific surplus, as well as the appropriate physical activity needed to promote muscle gain. Individual results may vary. Patients must adhere to the dietary guidelines set forth by our doctors. Use only as directed by the prescribing doctor, improper use may be harmful.